Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Intestinal research

Showing results (331-340 of 835) with videos related to

Pageof 84
Sort By:
Intestinal Research|November 19, 2020
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world studyTadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
Intestinal Research|June 1, 2022
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapiesPriscila A Lima, Bárbara B Berg, Marina Gomes Miranda E Castor
Intestinal Research|June 10, 2022
Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn's disease in tuberculosis endemic areasKaran Sachdeva, Peeyush Kumar, Bhaskar Kante, et al.
Intestinal Research|July 2, 2023
JAK inhibitor, a new player for treatment-refractory microscopic colitisAnne Druez, Simon Travis, Jean-François Rahier
Intestinal Research|May 19, 2025
Decoding genetic divergence: TPMT and NUDT15 polymorphisms in north India mirror Caucasian ancestryArshdeep Singh, Renu Moti Pandita, Manjeet Kumar Goyal, et al.
Intestinal Research|November 2, 2020
The first step to unveil the epidemiology of inflammatory bowel disease in Central AsiaSeung Wook Hong, Byong Duk Ye
Intestinal Research|November 2, 2020
Clinical management for small bowel of Crohn's disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesionKenji Watanabe
Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Intestinal Research|February 6, 2020
Hypermethylated promoters of tumor suppressor genes were identified in Crohn's disease patientsTae-Oh Kim, Yu Kyeong Han, Joo Mi Yi
Intestinal Research|July 22, 2021
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort studySeung Yong Shin, Soo Jung Park, Young Kim, et al.
Pageof 84

Showing results (331-340 of 835) with videos related to

Sort By:
Pageof 84
Intestinal Research|November 19, 2020
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world studyTadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
Intestinal Research|June 1, 2022
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapiesPriscila A Lima, Bárbara B Berg, Marina Gomes Miranda E Castor
Intestinal Research|June 10, 2022
Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn's disease in tuberculosis endemic areasKaran Sachdeva, Peeyush Kumar, Bhaskar Kante, et al.
Intestinal Research|July 2, 2023
JAK inhibitor, a new player for treatment-refractory microscopic colitisAnne Druez, Simon Travis, Jean-François Rahier
Intestinal Research|May 19, 2025
Decoding genetic divergence: TPMT and NUDT15 polymorphisms in north India mirror Caucasian ancestryArshdeep Singh, Renu Moti Pandita, Manjeet Kumar Goyal, et al.
Intestinal Research|November 2, 2020
The first step to unveil the epidemiology of inflammatory bowel disease in Central AsiaSeung Wook Hong, Byong Duk Ye
Intestinal Research|November 2, 2020
Clinical management for small bowel of Crohn's disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesionKenji Watanabe
Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Intestinal Research|February 6, 2020
Hypermethylated promoters of tumor suppressor genes were identified in Crohn's disease patientsTae-Oh Kim, Yu Kyeong Han, Joo Mi Yi
Intestinal Research|July 22, 2021
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort studySeung Yong Shin, Soo Jung Park, Young Kim, et al.
Pageof 84